Loading...

ATHA ATHIRA PHARMA INC Capital Structure Changes 8-K Filing

THR

TH

ATHIRA PHARMA INC

(ATHA)

2025 8-K

Show Summary

Show Summary

Reverse Stock Splits

Financial Statements

Stock Listing Transfer

Financial Results

Financial Results

Nasdaq Compliance Notice

Executive Changes

Workforce Reduction

Clinical Trial Results

Earnings Report

Annual Meeting Results

Settlement Approval

Financial Results

Financial Results and Induc...

Financial Condition Announc...

Earnings Reports

Earnings Reports

Management Change

Earnings Reports

Financial Results Announcement

Equity Offering

External Links:

On May 29, 2025, Athira Pharma, Inc. held its Annual Meeting, where shareholders elected directors and ratified Ernst & Young as auditors, with a significant approval for a reverse stock split. The stockholders authorized a split ratio of 5:1 to 20:1

AI Assistant

ATHIRA PHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.